Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2023

Feb 21, 2023

30016_dirs_2023-02-21_607ef5f7-85f2-4726-a2f1-516eaaacd4af.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2023-02-16

Reporting Person: AYERS JONATHAN W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-16 Common Stock G 1000 Disposed 145520 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 450000 Indirect
Common Stock 10000 Indirect

Footnotes

F1: The reporting person is the grantor and trustee of the Jonathan W. Ayers 2022 GRAT (the "GRAT"). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.